1 Report Overview 1.1 Study Scope 1.2 Key Market Segments 1.3 Players Covered: Ranking by Pharmacovigilance (PV) Revenue 1.4 Market by Type 1.4.1 Global Pharmacovigilance (PV) Market Size Growth Rate by Type: 2020 VS 2026 1.4.2 Spontaneous Reporting 1.4.3 Intensified ADR Reporting 1.4.4 Targeted Spontaneous Reporting 1.4.5 Cohort Event Monitoring 1.4.6 EHR Mining 1.5 Market by Application 1.5.1 Global Pharmacovigilance (PV) Market Share by Application: 2020 VS 2026 1.5.2 Hospitals 1.5.3 Research Organizations 1.5.4 Industrial 1.6 Study Objectives 1.7 Years Considered 2 Global Growth Trends 2.1 Global Pharmacovigilance (PV) Market Perspective (2015-2026) 2.2 Global Pharmacovigilance (PV) Growth Trends by Regions 2.2.1 Pharmacovigilance (PV) Market Size by Regions: 2015 VS 2020 VS 2026 2.2.2 Pharmacovigilance (PV) Historic Market Share by Regions (2015-2020) 2.2.3 Pharmacovigilance (PV) Forecasted Market Size by Regions (2021-2026) 2.3 Industry Trends and Growth Strategy 2.3.1 Market Top Trends 2.3.2 Market Drivers 2.3.3 Market Challenges 2.3.4 Porter’s Five Forces Analysis 2.3.5 Pharmacovigilance (PV) Market Growth Strategy 2.3.6 Primary Interviews with Key Pharmacovigilance (PV) Players (Opinion Leaders) 3 Competition Landscape by Key Players 3.1 Global Top Pharmacovigilance (PV) Players by Market Size 3.1.1 Global Top Pharmacovigilance (PV) Players by Revenue (2015-2020) 3.1.2 Global Pharmacovigilance (PV) Revenue Market Share by Players (2015-2020) 3.1.3 Global Pharmacovigilance (PV) Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.2 Global Pharmacovigilance (PV) Market Concentration Ratio 3.2.1 Global Pharmacovigilance (PV) Market Concentration Ratio (CR5 and HHI) 3.2.2 Global Top 10 and Top 5 Companies by Pharmacovigilance (PV) Revenue in 2019 3.3 Pharmacovigilance (PV) Key Players Head office and Area Served 3.4 Key Players Pharmacovigilance (PV) Product Solution and Service 3.5 Date of Enter into Pharmacovigilance (PV) Market 3.6 Mergers & Acquisitions, Expansion Plans 4 Market Size by Type (2015-2026) 4.1 Global Pharmacovigilance (PV) Historic Market Size by Type (2015-2020) 4.2 Global Pharmacovigilance (PV) Forecasted Market Size by Type (2021-2026) 5 Market Size by Application (2015-2026) 5.1 Global Pharmacovigilance (PV) Market Size by Application (2015-2020) 5.2 Global Pharmacovigilance (PV) Forecasted Market Size by Application (2021-2026) 6 North America 6.1 North America Pharmacovigilance (PV) Market Size (2015-2020) 6.2 Pharmacovigilance (PV) Key Players in North America (2019-2020) 6.3 North America Pharmacovigilance (PV) Market Size by Type (2015-2020) 6.4 North America Pharmacovigilance (PV) Market Size by Application (2015-2020) 7 Europe 7.1 Europe Pharmacovigilance (PV) Market Size (2015-2020) 7.2 Pharmacovigilance (PV) Key Players in Europe (2019-2020) 7.3 Europe Pharmacovigilance (PV) Market Size by Type (2015-2020) 7.4 Europe Pharmacovigilance (PV) Market Size by Application (2015-2020) 8 China 8.1 China Pharmacovigilance (PV) Market Size (2015-2020) 8.2 Pharmacovigilance (PV) Key Players in China (2019-2020) 8.3 China Pharmacovigilance (PV) Market Size by Type (2015-2020) 8.4 China Pharmacovigilance (PV) Market Size by Application (2015-2020) 9 Japan 9.1 Japan Pharmacovigilance (PV) Market Size (2015-2020) 9.2 Pharmacovigilance (PV) Key Players in Japan (2019-2020) 9.3 Japan Pharmacovigilance (PV) Market Size by Type (2015-2020) 9.4 Japan Pharmacovigilance (PV) Market Size by Application (2015-2020) 10 Southeast Asia 10.1 Southeast Asia Pharmacovigilance (PV) Market Size (2015-2020) 10.2 Pharmacovigilance (PV) Key Players in Southeast Asia (2019-2020) 10.3 Southeast Asia Pharmacovigilance (PV) Market Size by Type (2015-2020) 10.4 Southeast Asia Pharmacovigilance (PV) Market Size by Application (2015-2020) 11 India 11.1 India Pharmacovigilance (PV) Market Size (2015-2020) 11.2 Pharmacovigilance (PV) Key Players in India (2019-2020) 11.3 India Pharmacovigilance (PV) Market Size by Type (2015-2020) 11.4 India Pharmacovigilance (PV) Market Size by Application (2015-2020) 12 Central & South America 12.1 Central & South America Pharmacovigilance (PV) Market Size (2015-2020) 12.2 Pharmacovigilance (PV) Key Players in Central & South America (2019-2020) 12.3 Central & South America Pharmacovigilance (PV) Market Size by Type (2015-2020) 12.4 Central & South America Pharmacovigilance (PV) Market Size by Application (2015-2020) 13 Key Players Profiles 13.1 Accenture 13.1.1 Accenture Company Details 13.1.2 Accenture Business Overview 13.1.3 Accenture Pharmacovigilance (PV) Introduction 13.1.4 Accenture Revenue in Pharmacovigilance (PV) Business (2015-2020)) 13.1.5 Accenture Recent Development 13.2 Clinquest Group B.V. 13.2.1 Clinquest Group B.V. Company Details 13.2.2 Clinquest Group B.V. Business Overview 13.2.3 Clinquest Group B.V. Pharmacovigilance (PV) Introduction 13.2.4 Clinquest Group B.V. Revenue in Pharmacovigilance (PV) Business (2015-2020) 13.2.5 Clinquest Group B.V. Recent Development 13.3 Cognizant 13.3.1 Cognizant Company Details 13.3.2 Cognizant Business Overview 13.3.3 Cognizant Pharmacovigilance (PV) Introduction 13.3.4 Cognizant Revenue in Pharmacovigilance (PV) Business (2015-2020) 13.3.5 Cognizant Recent Development 13.4 Laboratory Corporation of America Holdings 13.4.1 Laboratory Corporation of America Holdings Company Details 13.4.2 Laboratory Corporation of America Holdings Business Overview 13.4.3 Laboratory Corporation of America Holdings Pharmacovigilance (PV) Introduction 13.4.4 Laboratory Corporation of America Holdings Revenue in Pharmacovigilance (PV) Business (2015-2020) 13.4.5 Laboratory Corporation of America Holdings Recent Development 13.5 IBM Corporation 13.5.1 IBM Corporation Company Details 13.5.2 IBM Corporation Business Overview 13.5.3 IBM Corporation Pharmacovigilance (PV) Introduction 13.5.4 IBM Corporation Revenue in Pharmacovigilance (PV) Business (2015-2020) 13.5.5 IBM Corporation Recent Development 13.6 ArisGlobal 13.6.1 ArisGlobal Company Details 13.6.2 ArisGlobal Business Overview 13.6.3 ArisGlobal Pharmacovigilance (PV) Introduction 13.6.4 ArisGlobal Revenue in Pharmacovigilance (PV) Business (2015-2020) 13.6.5 ArisGlobal Recent Development 13.7 ICON plc. 13.7.1 ICON plc. Company Details 13.7.2 ICON plc. Business Overview 13.7.3 ICON plc. Pharmacovigilance (PV) Introduction 13.7.4 ICON plc. Revenue in Pharmacovigilance (PV) Business (2015-2020) 13.7.5 ICON plc. Recent Development 13.8 Capgemini 13.8.1 Capgemini Company Details 13.8.2 Capgemini Business Overview 13.8.3 Capgemini Pharmacovigilance (PV) Introduction 13.8.4 Capgemini Revenue in Pharmacovigilance (PV) Business (2015-2020) 13.8.5 Capgemini Recent Development 13.9 ITClinical 13.9.1 ITClinical Company Details 13.9.2 ITClinical Business Overview 13.9.3 ITClinical Pharmacovigilance (PV) Introduction 13.9.4 ITClinical Revenue in Pharmacovigilance (PV) Business (2015-2020) 13.9.5 ITClinical Recent Development 13.10 iMEDGlobal 13.10.1 iMEDGlobal Company Details 13.10.2 iMEDGlobal Business Overview 13.10.3 iMEDGlobal Pharmacovigilance (PV) Introduction 13.10.4 iMEDGlobal Revenue in Pharmacovigilance (PV) Business (2015-2020) 13.10.5 iMEDGlobal Recent Development 13.11 Foresight Group International AG 10.11.1 Foresight Group International AG Company Details 10.11.2 Foresight Group International AG Business Overview 10.11.3 Foresight Group International AG Pharmacovigilance (PV) Introduction 10.11.4 Foresight Group International AG Revenue in Pharmacovigilance (PV) Business (2015-2020) 10.11.5 Foresight Group International AG Recent Development 13.12 TAKE Solutions Ltd. 10.12.1 TAKE Solutions Ltd. Company Details 10.12.2 TAKE Solutions Ltd. Business Overview 10.12.3 TAKE Solutions Ltd. Pharmacovigilance (PV) Introduction 10.12.4 TAKE Solutions Ltd. Revenue in Pharmacovigilance (PV) Business (2015-2020) 10.12.5 TAKE Solutions Ltd. Recent Development 13.13 PAREXEL International Corporation 10.13.1 PAREXEL International Corporation Company Details 10.13.2 PAREXEL International Corporation Business Overview 10.13.3 PAREXEL International Corporation Pharmacovigilance (PV) Introduction 10.13.4 PAREXEL International Corporation Revenue in Pharmacovigilance (PV) Business (2015-2020) 10.13.5 PAREXEL International Corporation Recent Development 13.14 BioClinica 10.14.1 BioClinica Company Details 10.14.2 BioClinica Business Overview 10.14.3 BioClinica Pharmacovigilance (PV) Introduction 10.14.4 BioClinica Revenue in Pharmacovigilance (PV) Business (2015-2020) 10.14.5 BioClinica Recent Development 13.15 Wipro Ltd. 10.15.1 Wipro Ltd. Company Details 10.15.2 Wipro Ltd. Business Overview 10.15.3 Wipro Ltd. Pharmacovigilance (PV) Introduction 10.15.4 Wipro Ltd. Revenue in Pharmacovigilance (PV) Business (2015-2020) 10.15.5 Wipro Ltd. Recent Development 13.16 United BioSource Corporation 10.16.1 United BioSource Corporation Company Details 10.16.2 United BioSource Corporation Business Overview 10.16.3 United BioSource Corporation Pharmacovigilance (PV) Introduction 10.16.4 United BioSource Corporation Revenue in Pharmacovigilance (PV) Business (2015-2020) 10.16.5 United BioSource Corporation Recent Development 14 Analyst's Viewpoints/Conclusions 15 Appendix 15.1 Research Methodology 15.1.1 Methodology/Research Approach 15.1.2 Data Source 15.2 Disclaimer 15.3 Author Details

List of Tables Table 1. Pharmacovigilance (PV) Key Market Segments Table 2. Key Players Covered: Ranking by Pharmacovigilance (PV) Revenue Table 3. Ranking of Global Top Pharmacovigilance (PV) Manufacturers by Revenue (US$ Million) in 2019 Table 4. Global Pharmacovigilance (PV) Market Size Growth Rate by Type (US$ Million): 2020 VS 2026 Table 5. Key Players of Spontaneous Reporting Table 6. Key Players of Intensified ADR Reporting Table 7. Key Players of Targeted Spontaneous Reporting Table 8. Key Players of Cohort Event Monitoring Table 9. Key Players of EHR Mining Table 10. Global Pharmacovigilance (PV) Market Size Growth by Application (US$ Million): 2020 VS 2026 Table 11. Global Pharmacovigilance (PV) Market Size by Regions (US$ Million): 2020 VS 2026 Table 12. Global Pharmacovigilance (PV) Market Size by Regions (2015-2020) (US$ Million) Table 13. Global Pharmacovigilance (PV) Market Share by Regions (2015-2020) Table 14. Global Pharmacovigilance (PV) Forecasted Market Size by Regions (2021-2026) (US$ Million) Table 15. Global Pharmacovigilance (PV) Market Share by Regions (2021-2026) Table 16. Market Top Trends Table 17. Key Drivers: Impact Analysis Table 18. Key Challenges Table 19. Pharmacovigilance (PV) Market Growth Strategy Table 20. Main Points Interviewed from Key Pharmacovigilance (PV) Players Table 21. Global Pharmacovigilance (PV) Revenue by Players (2015-2020) (Million US$) Table 22. Global Pharmacovigilance (PV) Market Share by Players (2015-2020) Table 23. Global Top Pharmacovigilance (PV) Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pharmacovigilance (PV) as of 2019) Table 24. Global Pharmacovigilance (PV) by Players Market Concentration Ratio (CR5 and HHI) Table 25. Key Players Headquarters and Area Served Table 26. Key Players Pharmacovigilance (PV) Product Solution and Service Table 27. Date of Enter into Pharmacovigilance (PV) Market Table 28. Mergers & Acquisitions, Expansion Plans Table 29. Global Pharmacovigilance (PV) Market Size by Type (2015-2020) (Million US$) Table 30. Global Pharmacovigilance (PV) Market Size Share by Type (2015-2020) Table 31. Global Pharmacovigilance (PV) Revenue Market Share by Type (2021-2026) Table 32. Global Pharmacovigilance (PV) Market Size Share by Application (2015-2020) Table 33. Global Pharmacovigilance (PV) Market Size by Application (2015-2020) (Million US$) Table 34. Global Pharmacovigilance (PV) Market Size Share by Application (2021-2026) Table 35. North America Key Players Pharmacovigilance (PV) Revenue (2019-2020) (Million US$) Table 36. North America Key Players Pharmacovigilance (PV) Market Share (2019-2020) Table 37. North America Pharmacovigilance (PV) Market Size by Type (2015-2020) (Million US$) Table 38. North America Pharmacovigilance (PV) Market Share by Type (2015-2020) Table 39. North America Pharmacovigilance (PV) Market Size by Application (2015-2020) (Million US$) Table 40. North America Pharmacovigilance (PV) Market Share by Application (2015-2020) Table 41. Europe Key Players Pharmacovigilance (PV) Revenue (2019-2020) (Million US$) Table 42. Europe Key Players Pharmacovigilance (PV) Market Share (2019-2020) Table 43. Europe Pharmacovigilance (PV) Market Size by Type (2015-2020) (Million US$) Table 44. Europe Pharmacovigilance (PV) Market Share by Type (2015-2020) Table 45. Europe Pharmacovigilance (PV) Market Size by Application (2015-2020) (Million US$) Table 46. Europe Pharmacovigilance (PV) Market Share by Application (2015-2020) Table 47. China Key Players Pharmacovigilance (PV) Revenue (2019-2020) (Million US$) Table 48. China Key Players Pharmacovigilance (PV) Market Share (2019-2020) Table 49. China Pharmacovigilance (PV) Market Size by Type (2015-2020) (Million US$) Table 50. China Pharmacovigilance (PV) Market Share by Type (2015-2020) Table 51. China Pharmacovigilance (PV) Market Size by Application (2015-2020) (Million US$) Table 52. China Pharmacovigilance (PV) Market Share by Application (2015-2020) Table 53. Japan Key Players Pharmacovigilance (PV) Revenue (2019-2020) (Million US$) Table 54. Japan Key Players Pharmacovigilance (PV) Market Share (2019-2020) Table 55. Japan Pharmacovigilance (PV) Market Size by Type (2015-2020) (Million US$) Table 56. Japan Pharmacovigilance (PV) Market Share by Type (2015-2020) Table 57. Japan Pharmacovigilance (PV) Market Size by Application (2015-2020) (Million US$) Table 58. Japan Pharmacovigilance (PV) Market Share by Application (2015-2020) Table 59. Southeast Asia Key Players Pharmacovigilance (PV) Revenue (2019-2020) (Million US$) Table 60. Southeast Asia Key Players Pharmacovigilance (PV) Market Share (2019-2020) Table 61. Southeast Asia Pharmacovigilance (PV) Market Size by Type (2015-2020) (Million US$) Table 62. Southeast Asia Pharmacovigilance (PV) Market Share by Type (2015-2020) Table 63. Southeast Asia Pharmacovigilance (PV) Market Size by Application (2015-2020) (Million US$) Table 64. Southeast Asia Pharmacovigilance (PV) Market Share by Application (2015-2020) Table 65. India Key Players Pharmacovigilance (PV) Revenue (2019-2020) (Million US$) Table 66. India Key Players Pharmacovigilance (PV) Market Share (2019-2020) Table 67. India Pharmacovigilance (PV) Market Size by Type (2015-2020) (Million US$) Table 68. India Pharmacovigilance (PV) Market Share by Type (2015-2020) Table 69. India Pharmacovigilance (PV) Market Size by Application (2015-2020) (Million US$) Table 70. India Pharmacovigilance (PV) Market Share by Application (2015-2020) Table 71. Central & South America Key Players Pharmacovigilance (PV) Revenue (2019-2020) (Million US$) Table 72. Central & South America Key Players Pharmacovigilance (PV) Market Share (2019-2020) Table 73. Central & South America Pharmacovigilance (PV) Market Size by Type (2015-2020) (Million US$) Table 74. Central & South America Pharmacovigilance (PV) Market Share by Type (2015-2020) Table 75. Central & South America Pharmacovigilance (PV) Market Size by Application (2015-2020) (Million US$) Table 76. Central & South America Pharmacovigilance (PV) Market Share by Application (2015-2020) Table 77. Accenture Company Details Table 78. Accenture Business Overview Table 79. Accenture Product Table 80. Accenture Revenue in Pharmacovigilance (PV) Business (2015-2020) (Million US$) Table 81. Accenture Recent Development Table 82. Clinquest Group B.V. Company Details Table 83. Clinquest Group B.V. Business Overview Table 84. Clinquest Group B.V. Product Table 85. Clinquest Group B.V. Revenue in Pharmacovigilance (PV) Business (2015-2020) (Million US$) Table 86. Clinquest Group B.V. Recent Development Table 87. Cognizant Company Details Table 88. Cognizant Business Overview Table 89. Cognizant Product Table 90. Cognizant Revenue in Pharmacovigilance (PV) Business (2015-2020) (Million US$) Table 91. Cognizant Recent Development Table 92. Laboratory Corporation of America Holdings Company Details Table 93. Laboratory Corporation of America Holdings Business Overview Table 94. Laboratory Corporation of America Holdings Product Table 95. Laboratory Corporation of America Holdings Revenue in Pharmacovigilance (PV) Business (2015-2020) (Million US$) Table 96. Laboratory Corporation of America Holdings Recent Development Table 97. IBM Corporation Company Details Table 98. IBM Corporation Business Overview Table 99. IBM Corporation Product Table 100. IBM Corporation Revenue in Pharmacovigilance (PV) Business (2015-2020) (Million US$) Table 101. IBM Corporation Recent Development Table 102. ArisGlobal Company Details Table 103. ArisGlobal Business Overview Table 104. ArisGlobal Product Table 105. ArisGlobal Revenue in Pharmacovigilance (PV) Business (2015-2020) (Million US$) Table 106. ArisGlobal Recent Development Table 107. ICON plc. Company Details Table 108. ICON plc. Business Overview Table 109. ICON plc. Product Table 110. ICON plc. Revenue in Pharmacovigilance (PV) Business (2015-2020) (Million US$) Table 111. ICON plc. Recent Development Table 112. Capgemini Business Overview Table 113. Capgemini Product Table 114. Capgemini Company Details Table 115. Capgemini Revenue in Pharmacovigilance (PV) Business (2015-2020) (Million US$) Table 116. Capgemini Recent Development Table 117. ITClinical Company Details Table 118. ITClinical Business Overview Table 119. ITClinical Product Table 120. ITClinical Revenue in Pharmacovigilance (PV) Business (2015-2020) (Million US$) Table 121. ITClinical Recent Development Table 122. iMEDGlobal Company Details Table 123. iMEDGlobal Business Overview Table 124. iMEDGlobal Product Table 125. iMEDGlobal Revenue in Pharmacovigilance (PV) Business (2015-2020) (Million US$) Table 126. iMEDGlobal Recent Development Table 127. Foresight Group International AG Company Details Table 128. Foresight Group International AG Business Overview Table 129. Foresight Group International AG Product Table 130. Foresight Group International AG Revenue in Pharmacovigilance (PV) Business (2015-2020) (Million US$) Table 131. Foresight Group International AG Recent Development Table 132. TAKE Solutions Ltd. Company Details Table 133. TAKE Solutions Ltd. Business Overview Table 134. TAKE Solutions Ltd. Product Table 135. TAKE Solutions Ltd. Revenue in Pharmacovigilance (PV) Business (2015-2020) (Million US$) Table 136. TAKE Solutions Ltd. Recent Development Table 137. PAREXEL International Corporation Company Details Table 138. PAREXEL International Corporation Business Overview Table 139. PAREXEL International Corporation Product Table 140. PAREXEL International Corporation Revenue in Pharmacovigilance (PV) Business (2015-2020) (Million US$) Table 141. PAREXEL International Corporation Recent Development Table 142. BioClinica Company Details Table 143. BioClinica Business Overview Table 144. BioClinica Product Table 145. BioClinica Revenue in Pharmacovigilance (PV) Business (2015-2020) (Million US$) Table 146. BioClinica Recent Development Table 147. Wipro Ltd. Company Details Table 148. Wipro Ltd. Business Overview Table 149. Wipro Ltd. Product Table 150. Wipro Ltd. Revenue in Pharmacovigilance (PV) Business (2015-2020) (Million US$) Table 151. Wipro Ltd. Recent Development Table 152. United BioSource Corporation Company Details Table 153. United BioSource Corporation Business Overview Table 154. United BioSource Corporation Product Table 155. United BioSource Corporation Revenue in Pharmacovigilance (PV) Business (2015-2020) (Million US$) Table 156. United BioSource Corporation Recent Development Table 157. Research Programs/Design for This Report Table 158. Key Data Information from Secondary Sources Table 159. Key Data Information from Primary Sources List of Figures Figure 1. Global Pharmacovigilance (PV) Market Share by Type: 2020 VS 2026 Figure 2. Spontaneous Reporting Features Figure 3. Intensified ADR Reporting Features Figure 4. Targeted Spontaneous Reporting Features Figure 5. Cohort Event Monitoring Features Figure 6. EHR Mining Features Figure 7. Global Pharmacovigilance (PV) Market Share by Application: 2020 VS 2026 Figure 8. Hospitals Case Studies Figure 9. Research Organizations Case Studies Figure 10. Industrial Case Studies Figure 11. Pharmacovigilance (PV) Report Years Considered Figure 12. Global Pharmacovigilance (PV) Market Size YoY Growth 2015-2026 (US$ Million) Figure 13. Global Pharmacovigilance (PV) Market Share by Regions: 2020 VS 2026 Figure 14. Global Pharmacovigilance (PV) Market Share by Regions (2021-2026) Figure 15. Porter's Five Forces Analysis Figure 16. Global Pharmacovigilance (PV) Market Share by Players in 2019 Figure 17. Global Top Pharmacovigilance (PV) Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pharmacovigilance (PV) as of 2019 Figure 18. The Top 10 and 5 Players Market Share by Pharmacovigilance (PV) Revenue in 2019 Figure 19. North America Pharmacovigilance (PV) Market Size YoY Growth (2015-2020) (Million US$) Figure 20. Europe Pharmacovigilance (PV) Market Size YoY Growth (2015-2020) (Million US$) Figure 21. China Pharmacovigilance (PV) Market Size YoY Growth (2015-2020) (Million US$) Figure 22. Japan Pharmacovigilance (PV) Market Size YoY Growth (2015-2020) (Million US$) Figure 23. Southeast Asia Pharmacovigilance (PV) Market Size YoY Growth (2015-2020) (Million US$) Figure 24. India Pharmacovigilance (PV) Market Size YoY Growth (2015-2020) (Million US$) Figure 25. Central & South America Pharmacovigilance (PV) Market Size YoY Growth (2015-2020) (Million US$) Figure 26. Bottom-up and Top-down Approaches for This Report Figure 27. Data Triangulation Figure 28. Key Executives Interviewed

Accenture Clinquest Group B.V. Cognizant Laboratory Corporation of America Holdings IBM Corporation ArisGlobal ICON plc. Capgemini ITClinical iMEDGlobal Foresight Group International AG TAKE Solutions Ltd. PAREXEL International Corporation BioClinica Wipro Ltd. United BioSource Corporation